|
TOR1AIP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.239750E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.388140E-02 |
| Normal-vs-Stage2 |
8.476100E-02 |
| Normal-vs-Stage3 |
1.760240E-02 |
| Normal-vs-Stage4 |
7.090000E-02 |
| Stage1-vs-Stage2 |
9.232800E-01 |
| Stage1-vs-Stage3 |
9.141600E-01 |
| Stage1-vs-Stage4 |
7.797400E-01 |
| Stage2-vs-Stage3 |
8.750000E-01 |
| Stage2-vs-Stage4 |
8.960200E-01 |
| Stage3-vs-Stage4 |
7.344600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.828050E-02 |
| Normal-vs-AfricanAmerican |
9.127600E-01 |
| Normal-vs-Asian |
1.288430E-02 |
| Caucasian-vs-AfricanAmerican |
1.275820E-01 |
| Caucasian-vs-Asian |
5.779800E-01 |
| AfricanAmerican-vs-Asian |
7.615500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.143000E-03 |
| Normal-vs-Female |
3.171800E-02 |
| Male-vs-Female |
1.946980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.905660E-02 |
| Normal-vs-Age(41-60Yrs) |
1.590190E-02 |
| Normal-vs-Age(61-80Yrs) |
7.957900E-02 |
| Normal-vs-Age(81-100Yrs) |
9.086500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.532600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.418200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.535400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.323600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.119000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.257800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.187500E-02 |
| Classical-VS-Follicular |
1.770790E-04 |
| Classical-VS-Other |
5.474100E-02 |
| Classical-VS-Normal |
1.796650E-01 |
| Tall-VS-Follicular |
5.165400E-01 |
| Tall-VS-Other |
2.028800E-01 |
| Tall-VS-Normal |
6.104200E-03 |
| Follicular-VS-Other |
4.385800E-01 |
| Follicular-VS-Normal |
5.67550000000194E-05 |
| Other-VS-Normal |
9.518900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.897300E-03 |
| Normal-vs-N1 |
3.456400E-03 |
| N0-vs-N1 |
5.028400E-01 |
|
|
